Evidence map›Paper›PMID 38593140›Full record

ArticlePloS one2024

Prediction of cross-border spread of the COVID-19 pandemic: A predictive model for imported cases outside China.

Ying Wang, Fang Yuan, Yueqian Song, Huaxiang Rao, Lili Xiao, Huilin Guo, Xiaolong Zhang, Mufan Li, Jiayu Wang, Yi Zhou Ren and 2 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ying WangScience and Technology Research Center of China Customs, Beijing, China.
Fang YuanScience and Technology Research Center of China Customs, Beijing, China.
Yueqian SongScience and Technology Research Center of China Customs, Beijing, China.
Huaxiang RaoDepartment of Preventive Medicine, Changzhi Medical College, Changzhi, China.ORCID 0000-0002-6388-8276
Lili XiaoScience and Technology Research Center of China Customs, Beijing, China.
Huilin GuoScience and Technology Research Center of China Customs, Beijing, China.
Xiaolong ZhangScience and Technology Research Center of China Customs, Beijing, China.
Mufan LiSchool of Epidemiology and Public Health, Shanxi Medical University, Taiyuan, China.
Jiayu WangSchool of Epidemiology and Public Health, Shanxi Medical University, Taiyuan, China.
Yi Zhou RenSchool of Epidemiology and Public Health, Shanxi Medical University, Taiyuan, China.
Jie TianScience and Technology Research Center of China Customs, Beijing, China.
Jianzhou YangDepartment of Preventive Medicine, Changzhi Medical College, Changzhi, China.ORCID 0000-0001-5354-2290

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has been present globally for more than three years, and cross-border transmission has played an important role in its spread. Currently, most predictions of COVID-19 spread are limited to a country (or a region), and models for cross-border transmission risk assessment remain lacking. Information on imported COVID-19 cases reported from March 2020 to June 2022 was collected from the National Health Commission of China, and COVID-19 epidemic data of the countries of origin of the imported cases were collected on data websites such as WHO and Our World in Data. It is proposed to establish a prediction model suitable for the prevention and control of overseas importation of COVID-19. Firstly, the SIR model was used to fit the epidemic infection status of the countries where the cases were exported, and most of the r2 values of the fitted curves obtained were above 0.75, which indicated that the SIR model could well fit different countries and the infection status of the region. After fitting the epidemic infection status data of overseas exporting countries, on this basis, a SIR-multiple linear regression overseas import risk prediction combination model was established, which can predict the risk of overseas case importation, and the established overseas import risk model overall P <0.05, the adjusted R2 = 0.7, indicating that the SIR-multivariate linear regression overseas import risk prediction combination model can obtain better prediction results. Our model effectively estimates the risk of imported cases of COVID-19 from abroad.

Indexed as

COVID-19ChinaHumansLinear ModelsPandemicsSARS-CoV-2

Identifiers

PMID38593140
PMCPMC11003692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.